hfpef tirzepatide SUMMIT: Improves Outcomes and Quality of Life For Patients With and Obesity Tirzepatide benefits obese HFpEF patients

It reduces the production of glucagon from the alpha cells in the pancreas

Practical Sleep Hygiene Moves That Pair Well With Zepbound Limit late day napping so you build sleep pressure at night

Circulation 149 , 10041015 (2024)

For example, the SELECT trial showed a 20% improvement in major cardiovascular events (i.e., heart attacks, strokes, and deaths from those cases) in adults on weekly semaglutide who were overweight or obese (without diabetes) and with preexisting cardiovascular disease, as well as an improvement in all-cause mortality of 19%

Find out about Ozempic for weight loss and if it really works

Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience